EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Magnetic and Fluorescent Dual-Labeled Genetically Encoded Targeted Nanoparticles for Malignant Glioma Cell Tracking and Drug Delivery

Anna N Gabashvili, Nelly S Chmelyuk, Vera V Oda, Maria K Leonova, Viktoria A Sarkisova, Polina A Lazareva, Alevtina S Semkina, Nikolai A Belyakov, Timur R Nizamov, Petr I Nikitin iD

Pharmaceutics · 04.10.2023 · 15 (10) · 2422

DOI: 10.3390/pharmaceutics15102422 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 04.10.2023. Verfasst von Anna N Gabashvili und 9 weiteren Autor:innen. Beteiligte Einrichtung: Prokhorov General Physics Institute of the Russian Academy of Sciences, 38 Vavilov Street, 119991 Moscow, Russia. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Ministry of Science and Higher Education of the Russian Federation, Ministry of Science and Higher Education of the Russian Federation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Human glioblastoma multiforme (GBM) is a primary malignant brain tumor, a radically incurable disease characterized by rapid growth resistance to classical therapies, with a median patient survival of about 15 months. For decades, a plethora of approaches have been developed to make GBM therapy more precise and improve the diagnosis of this pathology. Targeted delivery mediated by the use of various molecules (monoclonal antibodies, ligands to overexpressed tumor receptors) is one of the promising methods to achieve this goal. Here we present a novel genetically encoded nanoscale dual-labeled system based on Quasibacillus thermotolerans (Qt) encapsulins exploiting biologically inspired designs with iron-containing nanoparticles as a cargo, conjugated with human fluorescent labeled transferrin (Tf) acting as a vector. It is known that the expression of transferrin receptors (TfR) in glioma cells is significantly higher compared to non-tumor cells, which enables the targeting of the resulting nanocarrier. The selectivity of binding of the obtained nanosystem to glioma cells was studied by qualitative and quantitative assessment of the accumulation of intracellular iron, as well as by magnetic particle quantification method and laser scanning confocal microscopy. Used approaches unambiguously demonstrated that transferrin-conjugated encapsulins were captured by glioma cells much more efficiently than by benign cells. The resulting bioinspired nanoplatform can be supplemented with a chemotherapeutic drug or genotherapeutic agent and used for targeted delivery of a therapeutic agent to malignant glioma cells. Additionally, the observed cell-assisted biosynthesis of magnetic nanoparticles could be an attractive way to achieve a narrow size distribution of particles for various applications.

Schlagwörter

Stichwörter der Autor:innen

encapsulinsfluorescenceiron biomineralizationmagnetic particle quantificationtarget delivery system

Autor:innen und Institutionen

  • Prokhorov General Physics Institute of the Russian Academy of Sciences, 38 Vavilov Street, 119991 Moscow, Russia.
  • Laboratory "Biomedical Nanomaterials", National University of Science and Technology "MISIS", Leninskiy Prospekt 4, 119049 Moscow, Russia.
  • Department of Medical Nanobiotechnology, Pirogov Russian National Research Medical University, 1 Ostrovityanova Street, 117997 Moscow, Russia.
  • MILLAB Group Ltd., 100/2 Dmitrovskoe Highway, 127247 Moscow, Russia.
  • Department of Physical Chemistry, National University of Science and Technology "MISIS", Leninskiy Prospekt 4, 119049 Moscow, Russia.
  • Biology Faculty, Lomonosov Moscow State University, 1 Leninskiy Gory, 119234 Moscow, Russia.

ORCID-Profile: Petr I Nikitin

Förderung

  • the Ministry of Science and Higher Education of the Russian Federation
  • Ministry of Science and Higher Education of the Russian Federation

Zitieren

APA

Gabashvili, A. N., Chmelyuk, N. S., Oda, V. V., Leonova, M. K., Sarkisova, V. A., Lazareva, P. A., Semkina, A. S., Belyakov, N. A., Nizamov, T. R., & Nikitin, P. I. (2023). Magnetic and Fluorescent Dual-Labeled Genetically Encoded Targeted Nanoparticles for Malignant Glioma Cell Tracking and Drug Delivery. Pharmaceutics, 15(10), 2422. https://doi.org/10.3390/pharmaceutics15102422

Vancouver

Gabashvili AN, Chmelyuk NS, Oda VV, Leonova MK, Sarkisova VA, Lazareva PA, et al. Magnetic and Fluorescent Dual-Labeled Genetically Encoded Targeted Nanoparticles for Malignant Glioma Cell Tracking and Drug Delivery. Pharmaceutics. 2023;15(10):2422. doi:10.3390/pharmaceutics15102422

BibTeX
@article{Gabashvili2023,
  author = {Gabashvili, Anna N and Chmelyuk, Nelly S and Oda, Vera V and Leonova, Maria K and Sarkisova, Viktoria A and Lazareva, Polina A and Semkina, Alevtina S and Belyakov, Nikolai A and Nizamov, Timur R and Nikitin, Petr I},
  title = {Magnetic and Fluorescent Dual-Labeled Genetically Encoded Targeted Nanoparticles for Malignant Glioma Cell Tracking and Drug Delivery},
  journal = {Pharmaceutics},
  year = {2023},
  volume = {15},
  number = {10},
  pages = {2422},
  doi = {10.3390/pharmaceutics15102422}
}
Kostenlos starten →